| Product Code: ETC7625870 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Carrier Screening Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Carrier Screening Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Carrier Screening Market - Industry Life Cycle |
3.4 Ireland Carrier Screening Market - Porter's Five Forces |
3.5 Ireland Carrier Screening Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 Ireland Carrier Screening Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 Ireland Carrier Screening Market Revenues & Volume Share, By Medical Condition, 2021 & 2031F |
3.8 Ireland Carrier Screening Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 Ireland Carrier Screening Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Ireland Carrier Screening Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about carrier screening and genetic testing in Ireland |
4.2.2 Rising prevalence of genetic disorders and hereditary diseases in the population |
4.2.3 Technological advancements in genetic testing and screening methods |
4.3 Market Restraints |
4.3.1 Limited access to carrier screening services in rural areas |
4.3.2 High cost associated with carrier screening tests |
4.3.3 Ethical and legal concerns related to genetic testing and screening practices |
5 Ireland Carrier Screening Market Trends |
6 Ireland Carrier Screening Market, By Types |
6.1 Ireland Carrier Screening Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Carrier Screening Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 Ireland Carrier Screening Market Revenues & Volume, By Molecular Screening Test, 2021- 2031F |
6.1.4 Ireland Carrier Screening Market Revenues & Volume, By Biochemical Screening Test, 2021- 2031F |
6.2 Ireland Carrier Screening Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Carrier Screening Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.2.3 Ireland Carrier Screening Market Revenues & Volume, By Tay-Sachs, 2021- 2031F |
6.2.4 Ireland Carrier Screening Market Revenues & Volume, By Gaucher Disease, 2021- 2031F |
6.2.5 Ireland Carrier Screening Market Revenues & Volume, By Sickle Cell Disease, 2021- 2031F |
6.2.6 Ireland Carrier Screening Market Revenues & Volume, By Spinal Muscular Atrophy, 2021- 2031F |
6.2.7 Ireland Carrier Screening Market Revenues & Volume, By Other Autosomal Recessive Genetic Disorders, 2021- 2031F |
6.3 Ireland Carrier Screening Market, By Medical Condition |
6.3.1 Overview and Analysis |
6.3.2 Ireland Carrier Screening Market Revenues & Volume, By Pulmonary Conditions, 2021- 2031F |
6.3.3 Ireland Carrier Screening Market Revenues & Volume, By Hematological Conditions, 2021- 2031F |
6.3.4 Ireland Carrier Screening Market Revenues & Volume, By Neurological Conditions, 2021- 2031F |
6.3.5 Ireland Carrier Screening Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Ireland Carrier Screening Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Ireland Carrier Screening Market Revenues & Volume, By DNA Sequencing, 2021- 2031F |
6.4.3 Ireland Carrier Screening Market Revenues & Volume, By Polymerase Chain Reaction, 2021- 2031F |
6.4.4 Ireland Carrier Screening Market Revenues & Volume, By Microarrays, 2021- 2031F |
6.4.5 Ireland Carrier Screening Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Ireland Carrier Screening Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Ireland Carrier Screening Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Ireland Carrier Screening Market Revenues & Volume, By Reference Laboratories, 2021- 2031F |
6.5.4 Ireland Carrier Screening Market Revenues & Volume, By Physician Offices and Clinics, 2021- 2031F |
6.5.5 Ireland Carrier Screening Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Carrier Screening Market Import-Export Trade Statistics |
7.1 Ireland Carrier Screening Market Export to Major Countries |
7.2 Ireland Carrier Screening Market Imports from Major Countries |
8 Ireland Carrier Screening Market Key Performance Indicators |
8.1 Number of healthcare providers offering carrier screening services in Ireland |
8.2 Adoption rate of carrier screening tests among target population |
8.3 Rate of reimbursement for carrier screening tests by healthcare insurance providers |
9 Ireland Carrier Screening Market - Opportunity Assessment |
9.1 Ireland Carrier Screening Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 Ireland Carrier Screening Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 Ireland Carrier Screening Market Opportunity Assessment, By Medical Condition, 2021 & 2031F |
9.4 Ireland Carrier Screening Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 Ireland Carrier Screening Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Ireland Carrier Screening Market - Competitive Landscape |
10.1 Ireland Carrier Screening Market Revenue Share, By Companies, 2024 |
10.2 Ireland Carrier Screening Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here